Synthesis and antiviral evaluation of 3-hydroxy-2-methylpyridin-4-one dideoxynucleoside derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 24, 2003, Pages 4371-4374

  Barral, Karine ^a   Hider, Robert C ^b   Balzarini, Jan ^c   Neyts, Johan ^c   De Clercq, Erik ^c   Camplo, Michel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; 3 HYDROXY 2 METHYLPYRIDIN 4 ONE; ANTIVIRUS AGENT; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; COXSACKIE VIRUS B4; DRUG SCREENING; DRUG SYNTHESIS; EMBRYO; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PARAINFLUENZA VIRUS 3; REOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SINDBIS VIRUS; TOROVIRUS; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0344496017     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.09.033     Document Type: Article

References (12)

1. Tilbrook, G. S.; Hider, R. C. Iron chelators for clinical use. In Metals Ions in Biological Systems; Sigel, A., Sigel, H., Eds.; Iron Transport and Storage in Microorganisms, Plants and Animals, Vol. 35, Marcel Dekker: New York, 1998; p.691.
2. Hider R.C., Liu Z.D., Piyamongkol S. Tran. Sci. 23:2000;201.
3. Lederman H.M., Cohen A., Lee J.W.W., Freedman M.H., Gelfand E.W. Blood. 64:1984;748.
4. Sappey C., Boelaert J.R., Legrand P.S., Forceille C., Favier A., Piette J. AIDS Res. Hum. Retroviruses. 11:1995;1049.
5. (a) Georgiou N.A., van der Bruggen T., Hider R.C., Marx J., Van Asbeck B.S. Eur. J. Clin. Invest. 32:2002;91 Georgiou, N. A.; van der Bruggen, T.; Oudshoorn, M.; Nottet, H.; Marx, J.; Van Asbeck, B. S. Trans. Sci. 2000, 23, 249. Georgiou, N. A.; van der Bruggen, T.; Oudshoorn, M.; Nottet, H.; Marx, J.; Van Asbeck, B. S. J. Clin. Virol. 2001, 20, 141.
6. Dobbin P.S., Hider R.C., Hall A.D., Taylor P.D., Sarpong P., Porter J.B., Xiao G., van der Helm D. J. Med. Chem. 36:1993;2448.
7. Niedballa U., Vorbrüggen H. J. Org. Chem. 39:1974;3668.
8. (a) Liu G., Bruenger F.W., Barrios A.M., Miller S.C. Nucleosides Nucleotides. 14:1995;1901 (b) Mao D.T., Driscoll J.S., Marquez V.E. J. Med. Chem. 27:1984;160.
9. Choi W.B., Wilson L.J., Yeola S., Liotta D.C. J. Am. Chem. Soc. 113:1991;9377.
10. Jung M.E., Lyster M.A. J. Org. Chem. 42:1977;3761.
11. Huang J.J., Rideout J.L., Martin G.E. Nucleosides Nucleotides. 14:1995;195.
12. Neyts J., Reymen D., Letourneur D., Jozefonvicz J., Schols D., Esté J., Andrei G., McKenna P., Witvrouw M., Ikeda S., Clement J., De Clercq E. Biochem. Pharmacol. 50:1995;743.